Karolinska Institutet, Karolinska University Hospital
Stockholm, 17176, Sweden
NCT Number: NCT05164185
There is an on-going discussion weather remote ischemic conditioning (RIC) is effective in limiting the damage of reperfusion injury in STEMI patients. The results from recent RCTs have been variable and most have not shown convincing positive results when analyzing hard endpoints. Hence, there is a great need to evaluate the impact of comorbidities on the effectiveness of RIC. Therefore, we have designed a study to evaluate the impact of hypercholesterolemia on the RIC response by evaluating ischemia-induced endothelial dysfunction.
Aim: To investigate the impact of hypercholesterolemia on the RIC response in counteracting ischemia-induced endothelial dysfunction.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Stockholm, 17176, Sweden
Study population:
We plan to include 12 poorly controlled/newly diagnosed subjects with familiar hypercholesterolemia (FH) and 12 age-matched control subjects.
Inclusion criteria
(FH subjects)
Exclusion criteria
Main exposure:
Remote ischemic conditioning, i.e. 4 cycles of 5 minutes of ischemia to the lower limb.
Comparision group:
Cross over design, patients preform the protocol twice, once with sham and once with RIC. Also a group of healthy matched controls will be recruited.
Outcome:
Change in FMD after 20 minutes of ischemia and 20 minutes of reperfusion with the exposure of either sham or RIC.
Design:
Randomized interventional cross-over.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Brief cycles of ischemia to a limb. A blood pressure cuff was placed around the right thigh and inflated to 200 mmHg for 4 cycles of 5 minutes.
Time frame: 20 min post-reperfusion
A ultrasound based technic for evaluation of endothelial function
Karolinska Institutet
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03634436
Dyslipidemias, Hypercholesteremia
Beijing, Beijing Municipality, China
View Trial DetailsNCT02850224
Blood Pressure, Body Weight
Detroit, Michigan, United States
View Trial DetailsNCT02722408
Dyslipidemias, Hypercholesteremia
Beverly Hills, California, United States
View Trial DetailsNCT02634151
Dyslipidemias, Hypercholesteremia
Birmingham, Alabama, United States
View Trial Details